MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Mallinckrodt PLC Company Profile (NYSE:MNK)

Consensus Ratings for Mallinckrodt PLC (NYSE:MNK) (?)
Ratings Breakdown: 4 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $95.33 (70.33% upside)

Analysts' Ratings History for Mallinckrodt PLC (NYSE:MNK)
Show:
DateFirmActionRatingPrice TargetActions
6/10/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman SachsInitiated CoverageNeutral$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016JPMorgan Chase & Co.Reiterated RatingNeutral$100.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Piper JaffrayBoost Price TargetOverweight$97.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Jefferies GroupReiterated RatingBuy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016GuggenheimReiterated RatingBuy$98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Northland SecuritiesReiterated RatingBuy$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Leerink SwannBoost Price TargetOutperform$82.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016NomuraReiterated RatingNeutral$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Deutsche BankLower Price TargetBuy$89.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015BarclaysReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2015Bank of AmericaLower Price TargetBuy$135.00 -> $131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2015BMO Capital MarketsLower Price TargetMarket Perform$110.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015CRT CapitalBoost Price TargetFairly Valued$84.00 -> $97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Buckingham ResearchBoost Price TargetBuy$107.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingMarket Perform$90.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/24/2014 forward)
Earnings History for Mallinckrodt PLC (NYSE:MNK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q216$1.72$2.01$878.70 million$918.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q116$1.77$2.00$888.33 million$915.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/23/2015Q415$1.77$1.84$869.41 million$882.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q315$1.82$2.05$983.81 million$965.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q215$1.48$1.72$860.89 million$909.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q115$1.55$1.84$880.12 million$866.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2014Q414$1.41$1.68$759.04 million$789.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q314$0.87$1.20$278.80 million$653.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q214$0.78$0.95$566.50 million$557.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q1$0.66$0.88$539.24 million$540.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013$0.85$1.02$572.57 million$552.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q3 2013$0.78$0.49$557.22 million$570.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Mallinckrodt PLC (NYSE:MNK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201610$1.64$1.87$1.77
Q2 20169$1.95$2.09$2.05
Q3 20165$1.97$2.33$2.12
Q4 20163$2.16$2.19$2.17
(Data provided by Zacks Investment Research)
Dividend History for Mallinckrodt PLC (NYSE:MNK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Mallinckrodt PLC (NYSE:MNK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/10/2016Hugh M O'neillVPBuy1,653$60.99$100,816.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Matthew K HarbaughCFOBuy500$59.37$29,685.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Mark TrudeauCEOBuy1,000$56.02$56,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Steven J RomanoVPBuy900$56.00$50,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Coleman N Lannum IIIVPBuy2,600$62.63$162,838.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Meredith B FischerVPBuy1,400$69.80$97,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Coleman N Lannum IIIVPBuy600$59.66$35,796.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Coleman N Lannum IIIVPBuy1,300$62.58$81,354.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Matthew K. HarbaughCFOBuy1,300$63.00$81,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Coleman N. Lannum IIIVPBuy800$66.37$53,096.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Coleman N Lannum IIISVPBuy500$72.50$36,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Terrance L CarlsonGeneral CounselBuy1,000$69.10$69,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Gary M. PhillipsVPBuy1,000$72.17$72,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2015Mark TrudeauCEOBuy1,350$65.89$88,951.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Coleman N Lannum IIISVPBuy1,200$66.86$80,232.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Meredith B FischerVPBuy2,200$66.93$147,246.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Terrance L CarlsonGeneral CounselBuy1,000$66.54$66,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Hugh M O'neillSVPBuy1,197$83.52$99,973.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Mark TrudeauCEOBuy1,000$83.08$83,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Coleman N Lannum IIISVPBuy2,375$88.52$210,235.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Mark TrudeauCEOBuy2,000$88.45$176,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Coleman N Lannum IIIVPBuy1,300$126.41$164,333.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Matthew K HarbaughCFOSell22,106$128.64$2,843,715.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Mario D SaltarelliVPSell4,580$127.44$583,675.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Don M BaileyDirectorSell51,417$122.45$6,296,011.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Sandra L HattenVPSell2,024$122.29$247,514.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Don M BaileyDirectorSell40,000$127.61$5,104,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Don M BaileyDirectorSell40,000$123.40$4,936,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Don M BaileyDirectorSell33,891$114.63$3,884,925.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Mark TrudeauCEOSell11,925$105.94$1,263,334.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Mark TrudeauCEOSell15,720$102.00$1,603,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Peter G EdwardsVPSell1,265$99.69$126,107.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Mark TrudeauCEOSell13,831$93.59$1,294,443.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Raymond J FureyVPSell5,441$85.90$467,381.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Don M BaileyDirectorSell221,177$85.23$18,850,915.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Raymond J FureyVPSell15,000$85.47$1,282,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Virgil D ThompsonDirectorSell25,000$83.76$2,094,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Raymond J FureyVPSell10,303$81.61$840,827.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014Raymond J FureyVPSell4,840$80.90$391,556.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Joseph A ZaccagninoDirectorBuy3,000$71.06$213,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Paulson & Co IncMajor ShareholderBuy132,100$69.80$9,220,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014J Martin CarrollDirectorBuy2,000$69.24$138,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Paulson & Co IncMajor ShareholderBuy467,900$68.78$32,182,162.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Paulson & Co IncMajor ShareholderBuy207,900$69.70$14,490,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Paulson & Co IncMajor ShareholderBuy700,200$70.15$49,119,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Paulson & Co IncMajor ShareholderBuy275,000$69.60$19,140,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Melvin D BoothDirectorBuy4,000$76.05$304,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Paulson & Co Incmajor shareholderBuy786,207$73.63$57,888,421.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Mark TrudeauCEOSell14,890$56.12$835,626.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Mallinckrodt PLC (NYSE:MNK)
DateHeadline
06/22/16 05:06 PMMallinckrodt plc (NYSE:MNK) Analyst Rating Consensus - Trade Calls
06/21/16 04:52 PMBiotechnology Leads in Health Care
06/21/16 04:52 PMCommit To Buy Mallinckrodt At $30, Earn 11.7% Using Options
06/21/16 09:40 AMMallinckrodt plc To Report Third Quarter Fiscal 2016 Results On Aug. 2, 2016 - PR Newswire (press release)
06/20/16 01:00 PMMallinckrodt Needs More Medicine -
06/20/16 05:15 AMMallinckrodt Plc (NYSE:MNK) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 05:03 PMMallinckrodt : Donates One Million Drug Deactivation Pouches To Support U.S. Fight Against Prescription Drug Abuse
06/17/16 08:01 AMTraded Price Fluctuations to Observe: Mallinckrodt plc (NYSE:MNK) , XOMA Corporation (NASDAQ:XOMA) - Street Updates
06/16/16 05:23 PMTwo Buzzers to Observe: Mallinckrodt plc (NYSE:MNK) , United Therapeutics Corporation (NASDAQ:UTHR) - Street Updates
06/16/16 03:45 PMMallinckrodt Donates One Million Drug Deactivation Pouches To Support U.S. Fight Against Prescription Drug Abuse - [PR Newswire] - ST. LOUIS, June 16, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty biopharmaceutical company, today announced that it will purchase and donate more than 1 million Deterra™ drug deactivation pouches to help combat one of the top public health threats in the U.S. today – abuse of prescription pain medications. Through this initiative, families can actively address concerns with the responsible use of pain medications and patient safety. "As a company focused on our patients and communities, Mallinckrodt has long been a strong advocate of addressing the complex issues of opioid misuse and abuse that cause so much harm to families," said Mark Trudeau, Mallinckrodt President and Chief Executive Officer.
06/14/16 10:00 AMGoldman Sachs Initiates Coverage on Mallinckrodt PLC to Neutral - TheFounders Daily
06/14/16 10:00 AMMallinckrodt PLC (NYSE:MNK) Needs Investors Attention - Street Report
06/13/16 08:08 AMHC Trending Hot Stocks: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Mallinckrodt PLC (NYSE:MNK) - share market updates (press release)
06/13/16 07:54 AMMallinckrodt Submits INDA For Synacthen Depot -
06/13/16 07:45 AMMallinckrodt Plc breached its 50 day moving average in a Bearish Manner : MNK-US : June 13, 2016 -
06/13/16 06:19 AMMallinckrodt Submits Investigational New Drug Application for Synacthen® Depot - [at noodls] - CHESTERFIELD, United Kingdom, June 13, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced it has submitted an Investigational New Drug ...
06/10/16 01:12 PMHas Valeant Gone Bottom Fishing? -
06/09/16 05:31 PMMallinckrodt plc (NYSE:MNK) Earns Rating Score Of 1.21 - RealistInvestor.com
06/09/16 08:06 AMStocks within Investors Screening: Mallinckrodt plc (NYSE:MNK) , Universal Health Services, Inc. (NYSE:UHS) - Street Updates
06/07/16 07:52 AMTraders Attention Alert: Mallinckrodt plc (NYSE:MNK) , Catalent, Inc. (NYSE:CTLT) - Street Updates
06/06/16 05:07 PMAnalysts Offer Insights on Healthcare Companies: Mallinckrodt plc (NYSE: MNK), Jazz Pharmaceuticals (NASDAQ ... - Analyst Ratings
06/06/16 08:56 AMMallinckrodt PLC (MNK) Research Coverage Started at Goldman Sachs - Let Me Know About This
06/05/16 07:53 AMOppenheimer Reaffirms “Buy” Rating for Mallinckrodt PLC (MNK) - Let Me Know About This
06/05/16 07:53 AMMallinckrodt PLC (MNK) PT Raised to $80.00 - Let Me Know About This
06/03/16 08:00 AMShare Rating Focus on Mallinckrodt plc (NYSE:MNK) - HNN - TheStreet.comShare Rating Focus on Mallinckrodt plc (NYSE:MNK)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.21 on shares of Mallinckrodt plc (NYSE:MNK). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...Price Target and Share Rating Watch Mallinckrodt plc (NYSE:MNK)The Postall 151 news articles »
06/03/16 08:00 AMStocks inside Analysts Spotlight: Allergan plc. (NYSE:AGN) , Mallinckrodt plc (NYSE:MNK) - Street Updates - Stocks inside Analysts Spotlight: Allergan plc. (NYSE:AGN) , Mallinckrodt plc (NYSE:MNK)Street UpdatesAllergan plc. (NYSE:AGN) accumulated +1.95%, closing at $247.12 after floating between $241.30 and $247.39. The company has market capitalization of $97.75B. It has twelve month low of $195.50 and twelve month high of $340.34. The recent traded ...and more »
06/02/16 05:34 PMInvestor's observing Biotech Stocks: Baxter International Inc. (NYSE:BAX) , Mallinckrodt plc (NYSE:MNK) - Is stories - Is storiesInvestor's observing Biotech Stocks: Baxter International Inc. (NYSE:BAX) , Mallinckrodt plc (NYSE:MNK)Is storiesIn most recently trading session on 6/1/2016, Mallinckrodt plc (NYSE:MNK) climbed +2.89% while traded on 1.68 million shares versus it's an average volume of 2.85 million shares. The company recorded the last trade with the price of $65.19. The stock ...and more »
06/02/16 05:34 PMMallinckrodt plc (NYSE:MNK) Quarterly EPS Estimate At $2.19 - Investor Newswire - Mallinckrodt plc (NYSE:MNK) Quarterly EPS Estimate At $2.19Investor NewswireFirst Call stated that Mallinckrodt plc (NYSE:MNK) can touch $90.23 in coming one year. For the next quarter, the per-share earnings target is $2.19 and for ongoing fiscal at $8.28. EPS target for next year is $8.90 versus the mean EPS of $3.98 last year.and more »
06/02/16 08:08 AMTarget Price and Stock Performance Rundown for Mallinckrodt plc (NYSE:MNK) - HNN - Target Price and Stock Performance Rundown for Mallinckrodt plc (NYSE:MNK)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Mallinckrodt plc (NYSE:MNK) shares ...and more »
06/01/16 05:43 PMMallinckrodt plc (NYSE:MNK) Quarterly EPS Estimate At $2.1900 - Investor Newswire - Mallinckrodt plc (NYSE:MNK) Quarterly EPS Estimate At $2.1900Investor NewswireFirst Call stated that Mallinckrodt plc (NYSE:MNK) can touch $90.2300 in coming one year. For the next quarter, the per-share earnings target is $2.1900 and for ongoing fiscal at $8.2800. EPS target for next year is $8.9000 versus the mean EPS of $3 ...and more »
06/01/16 08:06 AMStock Review and Earnings Check on Mallinckrodt plc (NYSE:MNK) - HNN - Stock Review and Earnings Check on Mallinckrodt plc (NYSE:MNK)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Mallinckrodt plc (NYSE:MNK) to ...and more »
06/01/16 08:06 AMHow Many Mallinckrodt PLC (NYSE:MNK)'s Analysts Are Bullish? - HNN - How Many Mallinckrodt PLC (NYSE:MNK)'s Analysts Are Bullish?HNNOut of 13 analysts covering Mallinckrodt (NYSE:MNK), 13 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 93% are positive. Mallinckrodt has been the topic of 23 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Below is a ...
06/01/16 08:06 AMStocks Recommendation Update: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Mallinckrodt plc (NYSE:MNK) - Street Updates - Stocks Recommendation Update: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , Mallinckrodt plc (NYSE:MNK)Street UpdatesOn 5/31/2016, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) ended trading session lower at $20.93 with -1.23%. The company traded a volume of 6.88 million shares as comparison to average volume of 6.45 million shares. During the 52 –week period, the ...and more »
05/31/16 05:29 AMUnder the Consideration of Analysts: Mallinckrodt PLC (NYSE:MNK) - The Point Review - The Point ReviewUnder the Consideration of Analysts: Mallinckrodt PLC (NYSE:MNK)The Point ReviewMallinckrodt PLC (NYSE:MNK) has grabbed the attention from analysts, when it saw a value increase of +2.20 percent in the last trading session. A total of 1.37 million shares exchanged hands during the intra-day trade compared with its average trading ...and more »
05/27/16 04:38 PMMallinckrodt Now #442 Largest Company, Surpassing F5 Networks - In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Mallinckrodt plc (NYSE:MNK) has taken over the #442 spot from F5 Networks, Inc. (NASDAQ:FFIV), according to The Online Investor. Click here to find out ...
05/26/16 09:34 PMStock Rating Review for Mallinckrodt plc (NYSE:MNK) - Wall Street Hints and News - Stock Rating Review for Mallinckrodt plc (NYSE:MNK)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.21 on shares of Mallinckrodt plc (NYSE:MNK). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/26/16 04:27 PMTraders Observing Biotech Stocks: MannKind Corporation (NASDAQ:MNKD) , Mallinckrodt plc (NYSE:MNK) - Is stories - Traders Observing Biotech Stocks: MannKind Corporation (NASDAQ:MNKD) , Mallinckrodt plc (NYSE:MNK)Is storiesIn most recently trading session on 5/25/2016, Mallinckrodt plc (NYSE:MNK) dropped -0.43% while traded on 1.85 million shares versus it's an average volume of 2.93 million shares. The company recorded the last trade with the price of $60.61. The stock ...and more »
05/26/16 07:32 AMTarget Check and Stock Performance Recap Mallinckrodt plc (NYSE:MNK) - Wall Street Hints and News - Target Check and Stock Performance Recap Mallinckrodt plc (NYSE:MNK)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Mallinckrodt plc (NYSE:MNK) ...and more »
05/26/16 05:38 AM5 Health Care Stocks Whose Charts Tell You to Wait to Buy -
05/25/16 04:14 PMEarnings Review and Stock Rundown for Mallinckrodt plc (NYSE:MNK) - Wall Street Hints and News - Earnings Review and Stock Rundown for Mallinckrodt plc (NYSE:MNK)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Mallinckrodt plc (NYSE:MNK) to post ...and more »
05/23/16 09:26 PMMallinckrodt And Citron: Scrutinizing The Scrutinizer - Seeking Alpha - Mallinckrodt And Citron: Scrutinizing The ScrutinizerSeeking AlphaMallinckrodt (NYSE:MNK) is a company that develops, manufactures, and sells specialty pharmaceutical and biopharmaceutical products in the United States and internationally. It has received a lot of attention, particularly over the last few months ...
05/23/16 04:19 PMHealthcare Stock showing Positive Movement: Mallinckrodt PLC (NYSE:MNK) - News Oracle - News OracleHealthcare Stock showing Positive Movement: Mallinckrodt PLC (NYSE:MNK)News OracleBy looking at Mallinckrodt PLC (NYSE:MNK) YTD (year to date) performance, the stock shows Negative value of -18.22%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is ...and more »
05/23/16 03:30 PMMallinckrodt Donates 250,000 Drug Deactivation Systems to ACT Missouri to Support Fight Against Prescription Drug Abuse - [PR Newswire] - ST. LOUIS, May 23, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced that it has purchased and donated 250,000 drug deactivation ...
05/23/16 09:06 AMTrending Biotech Stocks Update: Neovasc Inc. (NASDAQ:NVCN) , Mallinckrodt plc (NYSE:MNK) - Is stories - Is storiesTrending Biotech Stocks Update: Neovasc Inc. (NASDAQ:NVCN) , Mallinckrodt plc (NYSE:MNK)Is storiesIn most recently trading session on 5/20/2016, Mallinckrodt plc (NYSE:MNK) climbed +3.49% while traded on 1.7 million shares versus it's an average volume of 2.9 million shares. The company recorded the last trade with the price of $61.03. The stock ...
05/23/16 07:00 AMTrending Now: MNK -
05/20/16 09:04 AMHow Mallinckrodt’s Specialty Brands Performed in 2Q16 -
05/20/16 07:42 AMBiotech Movers Update: Johnson & Johnson (NYSE:JNJ) , Mallinckrodt plc (NYSE:MNK) - Is stories - Biotech Movers Update: Johnson & Johnson (NYSE:JNJ) , Mallinckrodt plc (NYSE:MNK)Is storiesMallinckrodt plc (NYSE:MNK) started out trading at $59.93 and hit to day high price of $61.30 while it touched the day low price of $58.42. Shares have gone down -2.64% to close at $58.97. The company shares changing hands with the volume of 1.82 ...and more »
05/19/16 09:27 PMTwo Biotech stocks to Watch: AbbVie Inc. (NYSE:ABBV) , Mallinckrodt plc (NYSE:MNK) - Is stories - Is storiesTwo Biotech stocks to Watch: AbbVie Inc. (NYSE:ABBV) , Mallinckrodt plc (NYSE:MNK)Is storiesIn most recently trading session on 5/18/2016, Mallinckrodt plc (NYSE:MNK) dropped -2.29% while traded on 2.02 million shares versus it's an average volume of 2.92 million shares. The company recorded the last trade with the price of $60.57. The stock ...and more »
05/19/16 03:03 PMETF’s with exposure to Mallinckrodt Plc : May 19, 2016 -
05/18/16 04:16 PMMallinckrodt plc (NYSE:MNK) One-Year Price Target Estimate At $90.23 - Stocks Daily - Mallinckrodt plc (NYSE:MNK) One-Year Price Target Estimate At $90.23Stocks DailyThe 52-week price target of Mallinckrodt plc (NYSE:MNK) is set at $90.23 after First Call completed its market based survey. It has estimated EPS of $2.18 for approaching quarter and $8.28 for ongoing year. The EPS estimate for next year is $8.90 ...and more »
About Mallinckrodt PLC

Mallinckrodt PLC logoMallinckrodt public limited company (Mallinckrodt) is engaged in the specialty pharmaceuticals and nuclear imaging business. The Company develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents. The Company's segments include Specialty Brands, Specialty Generics and Nuclear Imaging. Its Specialty Brands segment produces and markets branded pharmaceutical and biopharmaceutical products for autoimmune and rare diseases; immunotherapy and neonatal respiratory critical care therapies, and central nervous system drugs. Its Specialty Generics segment produces specialty generic pharmaceuticals and active pharmaceutical ingredients (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its Nuclear Imaging segment manufactures and markets radiopharmaceuticals (nuclear medicine).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: MNK
  • CUSIP:
Key Metrics:
  • Previous Close: $56.68
  • 50 Day Moving Average: $60.52
  • 200 Day Moving Average: $64.06
  • P/E Ratio: 14.74
  • P/E Growth: 0.70
  • Market Cap: $6.42B
  • Current Quarter EPS Consensus Estimate: $8.28 EPS
Additional Links:
Mallinckrodt PLC (NYSE:MNK) Chart for Friday, June, 24, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha